Join Us
Elevate Your Brand and Succeed with ACT
ACT maintains a highly visible, well-regarded presence in the toxicology community through educational programs, professional networking opportunities, and our scientific journal.
Corporate support is essential to the continued success of the College and the achievement of its goals, and the ACT corporate membership program is a highly visible way for companies with a vested interest in the field of toxicology to show their support for the vital work of the College. In return, ACT corporate members benefit by elevating their brand and credibility as an ACT partner.
Why Join Forces with ACT?
ACT is a leader in toxicology education, offering well-regarded resources:
- Signature Webinars
- ToxChats Podcasts
- Education Courses
- eLearning Seminars
- Annual Meeting—CE Courses, Symposia, Exhibition
- International Journal of Toxicology
Who We Are and Who You Reach
ACT members are professional scientists, postdocs, and students representing:
- Pharmaceutical and Biotech Industries
- Contract Research Organizations
- Regulatory Agencies
- Academia
- Consulting Firms
Corporate Partner ($3,500 per Year):
- Five job postings for six months each ($1,250 value)
- Enhanced listing with hyperlink in the membership Newsletter
- Enhanced listing with your logo in an issue of International Journal of Toxicology
- Recognition in the Program and on signage at the ACT Annual Meeting
- One blog post with your unique content in the ACTalks blog
- One additional Exhibitor Priority Point for companies that also exhibit at the Annual Meeting, and Priority exhibit booth selection at the Annual Meeting
- Logo on the ACT website home page
- ACT Corporate Member logo for use on your company website
- Enhanced listing on the ACT website with your logo, company description (30 words), and hyperlink to your company’s website
Corporate Contributor ($2,000 per Year):
- Two job postings for six months each ($500 value)
- Listing of company name in the membership Newsletter
- Listing of company name in an issue of International Journal of Toxicology
- Listing of company name with hyperlink on the ACT website
- Recognition in the Program and on signage at the ACT Annual Meeting
- Priority exhibit booth selection at the Annual Meeting in November
To take advantage of ACT Corporate Membership, please contact Art Shaw, 703.547.0875 ext. 1455.
ACT Corporate Partners 2023
Boehringer Ingelheim is driven by the desire to serve humankind by improving human and animal health. We work together globally and with integrity.
Learn more
Charles River has a global network of scientific experts offering robust safety assessments of drugs, devices, and chemicals. Experience with all molecules types and regulations to mitigate risk for development.
Learn more
Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases.
Learn more
Expect More: more attention, insight and a superlative experience. Inotiv delivers a comprehensive and integrated range of right-size in vivo discovery and tox services, BioA, pathology, DMPK and consulting solutions essential to your success.
Learn more
Lilly unites caring with discovery to create medicines that make life better for people around the world.
Learn more
Lovelace Biomedical is a preclinical contract research organization helping pharmaceutical and biotechnology companies advance their complex drug development studies, with multidisciplinary expertise in toxicology, gene therapy, infectious disease, medical countermeasures.
Learn more
Noble Life Sciences is a preclinical CRO with decades of experience in drug, vaccine, and device development. GLP and non-GLP services, PK/PD, safety, toxicology, and cell-based assays with a strong focus on oncology and infectious diseases.
Learn more
Hope changes lives. We’re in relentless pursuit of scientific breakthroughs and revolutionary medicines that will create a healthier world for everyone.
Learn more
Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. We consistently translate science into medicine, leading to nine FDA-approved treatments and numerous product candidates.
Learn moreCorporate Contributors
©Copyright American College of Toxicology All Rights Reserved